ASH 2016 Educational Session: Long-Term Risk of Second Malignancy and Cardiovascular Disease After Hodgkin Lymphoma Treatment
On Saturday 3 rd December , during the 58 th Annual Meeting & Exposition of the American Society of Hematology (ASH), in San Diego , CA, an…
Waldenström macroglobulinemia: Six-year follow-up of phase II trial into front-line BDR in the treatment of newly diagnosed…
In November 2016, Maria Gavriatopoulo u from the National and Kapodistrian University of Athens School of Medicine, Greece , and colleagues published…
Karl Kemp-O'Brien | Dec 20, 2016
ASH 2016: Is MRD testing performed by community hematologists?
Anne Villeneuve | Dec 19, 2016